Topical Discussion
Video

Class Effect Among Non-Hyperemic Pressure Ratios (NHPR)

September 24, 2018

07:34

Do all roads lead to Rome when it comes to non-hyperemic pressure ratios (NHPR)? Drs. Mort Kern, Nils Johnson, & Ziad Ali, discuss data presented at TCT 2018 on new options in coronary physiology, such as DFR, and which tool to use when…and why.

iFR
Imaging
nhpr
physiology
sponsored
Topical Discussion

Recommended Videos

University of Washington Medical Center, Seattle, WA - Balloon Expandable TMVR in Severe MAC sp SEASAME Procedure 42:51

University of Washington Medical Center, Seattle, WA - Balloon Expandable TMVR in Severe MAC sp SEASAME Procedure

Honor Health Medical Center, Scottsdale, AZ - Mitral TEER in Secondary MR 42:40

Honor Health Medical Center, Scottsdale, AZ - Mitral TEER in Secondary MR

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial) 47:20

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial)

University Hospital of Cologne, Department of Cardiology, Cologne, Germany - A Novel Transcatheter Tricuspid Valve Replacement for TR 43:41

University Hospital of Cologne, Department of Cardiology, Cologne, Germany - A Novel Transcatheter Tricuspid Valve Replacement for TR

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR 46:02

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR

Scripps ClinicScripps Memorial Hospital La Jolla, CA - Complex PCI – Calcified Coronary Treatment 42:48

Scripps ClinicScripps Memorial Hospital La Jolla, CA - Complex PCI – Calcified Coronary Treatment

Saint Luke’s Mid America Heart Institute, Kansas City, MO - Complex Coronary PCI (MVD) and Ischemic Cardiomyopathy 46:00

Saint Luke’s Mid America Heart Institute, Kansas City, MO - Complex Coronary PCI (MVD) and Ischemic Cardiomyopathy

AHA 2023 Wrap-Up 08:45

AHA 2023 Wrap-Up

Lead Management in Patients with Tricuspid Regurgitation and CIEDs 21:27

Lead Management in Patients with Tricuspid Regurgitation and CIEDs

Antiplatelet Decision Making in High-Risk PCI 00:43

Antiplatelet Decision Making in High-Risk PCI

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve 12:49

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

Beyond the Data: ORBITA-2 16:33

Beyond the Data: ORBITA-2

Beyond the Data: DAPA-MI 21:07

Beyond the Data: DAPA-MI

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis 05:36

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study 03:12

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial 42:51

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial

Topical Discussion

See All (143)
Lead Management in Patients with Tricuspid Regurgitation and CIEDs 21:27
TCT 2023

Lead Management in Patients with Tricuspid Regurgitation and CIEDs

Antiplatelet Decision Making in High-Risk PCI 00:43

Antiplatelet Decision Making in High-Risk PCI

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve 12:49
TCT 2023

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis 05:36
TCT 2023

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study 03:12

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial 42:51

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial

First Insights on the PARTNER 3 Trial 5-year Data 26:03
TCT 2023

First Insights on the PARTNER 3 Trial 5-year Data

Baroreflex Activation Therapy for HFrEF Patients- New Insights from the BeAT-HF Study 59:58

Baroreflex Activation Therapy for HFrEF Patients- New Insights from the BeAT-HF Study